Harmony Biosciences Holdings (HRMY) Inventory (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Inventory of $5.3 million for Q1 2026, down 4.35% sequentially from $5.5 million in Q4 2025, and down 17.28% YoY from $6.4 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) Inventory (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Inventory for 8 years, with the latest figure at $5.3 million in Q1 2026.
- Quarterly Inventory fell 17.28% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (down 17.28% YoY) and the FY2025 annual result came in at $5.5 million, down 23.3% from the prior year.
- Inventory retreated to $5.3 million in Q1 2026 per HRMY's latest filing, from $5.5 million in the prior quarter.
- Over five years, Inventory peaked at $7.2 million in Q4 2024 and troughed at $4.2 million in Q2 2022.
- A 5-year average of $5.6 million and a median of $5.4 million in 2023 frame the typical range for Inventory.
- The sharpest annual moves came in 2024 and 2025: Inventory surged 35.93% in 2024, then decreased 23.3% in 2025.
- Over 5 years, Inventory stood at $4.9 million in 2022, then gained by 9.09% to $5.4 million in 2023, then soared by 34.22% to $7.2 million in 2024, then fell by 23.3% to $5.5 million in 2025, then slipped by 4.35% to $5.3 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $5.3 million, $5.5 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.52 Mn |
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 5.36 Mn |
| Sep 30, 2023 | 5.09 Mn |
| Jun 30, 2023 | 4.85 Mn |
| Mar 31, 2023 | 4.71 Mn |
| Dec 31, 2022 | 4.92 Mn |
| Sep 30, 2022 | 4.54 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 5.05 Mn |
| Dec 31, 2021 | 4.88 Mn |
| Sep 30, 2021 | 5.25 Mn |